Cost-Effectiveness of Insulin Degludec Versus Insulin Glargine U100 in Patients with Type 1 and Type 2 Diabetes Mellitus in Serbia

INTRODUCTION: This study investigates the cost-effectiveness of insulin degludec versus insulin glargine U100 in patients with type 1 and type 2 diabetes mellitus in Serbia. METHODS: A cost-utility analysis, implementing a simple short-term model, was used to compare treatment costs and outcomes wit...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Diabetes Ther
Päätekijät: Lalić, Nebojša, Russel-Szymczyk, Monika, Culic, Marina, Tikkanen, Christian Klyver, Chubb, Barrie
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Springer Healthcare 2018
Aiheet:
Original Research
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC5984929/
https://ncbi.nlm.nih.gov/pubmed/29700772
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s13300-018-0426-0
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia